The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategies. [PDF]
Front Cardiovasc MedLi ZH, Wang XY, Luo Q.
europepmc +1 more source
The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial Cells [PDF]
, 2000 Nobushige Tanaka +5 more
openalex +1 more source
The Impact of Preeclampsia and Gestational Diabetes on Future Maternal Cardiometabolic Health
Acta Physiologica, Volume 241, Issue 11, November 2025.ABSTRACT Introduction Pregnancy is a time of significant maternal physiological change to meet the metabolic demands of the feto‐placental unit. In cases of pregnancy complications, mal‐adaptive physiological responses may occur, potentially impacting the health of both mother and fetus.
Alice M. Barrell +1 more
wiley +1 more source
Advanced glycation end products induce inflammaging in periodontal ligament fibroblasts through RAGE/AKT/mTOR/glycolysis pathway. [PDF]
Acta Odontol ScandXiong L +7 more
europepmc +1 more source
Glycation impairs high-density lipoprotein function [PDF]
, 2000 Catherine C. Hedrick +7 more
openalex +1 more source
British Journal of Pharmacology, Volume 182, Issue 21, Page 5355-5377, November 2025.Background and purpose Diabetic nephropathy (DN) is a common complication of diabetes. Current treatments include renin‐angiotensin‐aldosterone system (RAAS) blockers and sodium‐glucose co‐transporter 2 (SGLT2) inhibitors. The cannabinoid CB1 receptor is a potential therapeutic target.
Océane Pointeau +20 more
wiley +1 more source
Distinct patterns of association between the hemoglobin glycation index, the stress-hyperglycemia ratio, and the risk of new-onset atrial fibrillation in critically ill patients. [PDF]
Front Endocrinol (Lausanne)Jie Q +6 more
europepmc +1 more source